Wednesday
SESSION 25: NEW DEVELOPMENTS IN LOWER EXTREMITY RELATED TOPICS: DOWNSIDE OF DCBs: THE PACLITAXEL COATED DEVICES INCREASE MORTALITY ISSUE
Location: Grand Ballroom East, 3rd Floor
Moderators:Kenneth Ouriel, MD, MBA / Gary M. Ansel, MD  
SESSION 25 SCHEDULE
9:10 AM - 9:15 AM Introductory Remarks And Overview
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:16 AM - 9:21 AM The Downsides To DCBs: Cost; Distal Embolization; Increased Mortality: Are They Substantive
  Presenter(s):Andrew Holden, MBChB  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:22 AM - 9:27 AM Update On The Meta-Analysis Showing An Increased Mortality In Patients Treated With Drug (Paclitaxel) Coated Lower Extremity Devices (DCBs And DESs): What Is The Current Interpretation
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:28 AM - 9:33 AM Understanding The Pharmacology, Mechanisms Of Action And Toxicity Of Paclitaxel On Drug Coated Devices: How Could Paclitaxel Influence Mortality
  Presenter(s):Juan F. Granada, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:34 AM - 9:39 AM Is The Increased Mortality Risk Of Paclitaxel Coated Lower Extremity Devices Observed In The Meta-Analysis Real And Meaningful: Update From The VIVA Leaders Analysis: Currently How Should It Influence Use Of These Devices: Where Is This Issue Going
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:40 AM - 9:45 AM Current Status Of The Discussion On Paclitaxel Coated Lower Extremity Devices And Their Impact On Patient Mortality: Another View And Where Does The FDA Stand And Why
  Presenter(s):Michael R. Jaff, DO  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:46 AM - 9:51 AM What Is The Society for Vascular Surgery (SVS) Doing About This Issue And Where Does It Stand On It
  Presenter(s):Kim J. Hodgson, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:52 AM - 9:57 AM What Is The Response To And Position Of An Industry Partner (Medtronic) Which Is Vested In Drug Eluting Technology
  Presenter(s):Mark Pacyna  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:58 AM - 10:03 AM Update On The Late Results (> 5 Years) Of The Zilver PTX DES Trials That Are Relevant To This Issue: Including The Corrected Late Patient Mortality Data
  Presenter(s):Michael D. Dake, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:04 AM - 10:09 AM Long-Term Safety And Effectiveness Of Paclitaxel Coated Devices Versus Non-Coated Devices For Fempop Occlusive Lesions: From Japanese RCTs And Registries: How Do These Data Bear On The Paclitaxel-Mortality Issue
  Presenter(s):Osamu Iida, MD / Hiroyoshi Yokoi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:10 AM - 10:15 AM 6-Year Comparison Of Mortality And Its Causes In 1500 Patients Treated With Paclitaxel Coated DCBs Or DESs Versus Bare Metal Stents (BMSs) Or Plain Old Balloon Angioplasty (POBA)
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:16 AM - 10:19 AM Large Population Based Multicenter German Study Indicates Paclitaxel Coated Devices May Be Associated With Lower Late Mortality Than Uncoated Devices In Some Patient Subgroups
  Presenter(s):Christian A. Behrendt, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:19 AM - 10:25 AM Panel Discussion
END OF SESSION 25
previous next